Tirzepatide compounding outcome: Restricted with shortage carve-out
53%YES chance
Yes
53%
No
47%
Now 52.7%
Resolution
Resolves to the FDA's final position on compounded tirzepatide by EOY 2026.
Source: https://www.fda.gov/
Resolves by Jan 28, 2027.
Recent trades
- NO@haydenlopez149 sh@ 53%65 SP
- NO@logantorres206.1 sh@ 60%73 SP
- YES@kaiunderhill120.4 sh@ 69%80 SP
- NO@lanewalsh39.8 sh@ 44%22 SP
- YES@alexalvarez26.9 sh@ 64%17 SP
- YES@juneyoon106.3 sh@ 63%64 SP
- YES@briarlopez47.1 sh@ 46%21 SP
- NO@averylopez43.6 sh@ 58%18 SP
- YES@micahashworth138.2 sh@ 60%78 SP
- YES@remymoss58.1 sh@ 53%30 SP
- YES@alexalvarez174.6 sh@ 50%80 SP
- NO@taylorvargas145.7 sh@ 42%80 SP
- NO@elliskhan64.4 sh@ 49%32 SP
- YES@grayhale80.1 sh@ 52%40 SP
- NO@alexkhan109.4 sh@ 48%54 SP
- NO@reesekhan133.2 sh@ 43%71 SP
- YES@briarlopez59.7 sh@ 53%31 SP
- YES@juneyoon133.9 sh@ 50%63 SP
Top holders
YES holders
No holders yet.
NO holders
No holders yet.
News
Refreshed every 6 hours
No news yet. Endcap's news crawler refreshes every 6 hours.
Discussion
- @drewhayesDrew Hayes8 days ago
the tape is the tape.